Key messages from EBC MAIN at three years


EBC MAIN investigator David Hildick-Smith (Brighton, UK) delivers key messages from the trial’s three-year results, presented for the first time at EuroPCR 2023 (16–19 May, Paris, France).

The randomised trial compares a provisional versus a systematic dual stent strategy for true bifurcation left main coronary artery disease at over 30 centres across Europe.

Among the important takeaway messages from the trial, Hildick-Smith tells Cardiovascular News, is that interventionalists do not need to decide on the number of stents they intend to use prior to the procedure.


Please enter your comment!
Please enter your name here